• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PerkinElmer (NY:PKI)

N/A UNCHANGED
Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PerkinElmer

< Previous 1 2 3 4 5 6 Next >
News headline image
PerkinElmer Offloads Applied, Food & Enterprise Services Businesses For ~$2.5B ↗
August 01, 2022
 
Via Benzinga
News headline image
PerkinElmer: Q2 Earnings Insights ↗
August 01, 2022
  PerkinElmer (NYSE:PKI) reported its Q2 earnings results on Monday, August 1, 2022 at 06:12 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
August 01, 2022
From New Mountain Capital
Via Business Wire
News headline image
PerkinElmer Announces Financial Results for the Second Quarter of 2022
August 01, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
What 4 Analyst Ratings Have To Say About PerkinElmer ↗
July 14, 2022
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter: 
Via Benzinga
News headline image
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
August 01, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Board Declares Quarterly Dividend
July 22, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
July 22, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022 ↗
July 20, 2022
Upgrades 
Via Benzinga
News headline image
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
July 14, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗
July 13, 2022
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022 ↗
July 05, 2022
Upgrades 
Via Benzinga
News headline image
PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
June 21, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Launches BioQule NGS System to Automate Library Preparation
June 06, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022 ↗
May 18, 2022
 
Via Benzinga
News headline image
Recap: PerkinElmer Q1 Earnings ↗
May 03, 2022
PerkinElmer (NYSE:PKI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings PerkinElmer beat estimated earnings by... 
Via Benzinga
News headline image
PerkinElmer Announces Financial Results for the First Quarter of 2022
May 03, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 3, 2022 ↗
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. 
Via Benzinga
News headline image
PerkinElmer Board Declares Quarterly Dividend
April 28, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis ↗
April 20, 2022
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was... 
Via Benzinga
News headline image
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
April 12, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
April 07, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
April 04, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
Death Cross Looms Over PerkinElmer Investors ↗
March 31, 2022
If history is any guide, there may be trouble ahead for shares of PerkinElmer (NYSE:PKI). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
News headline image
7 Healthcare Stocks to Buy for the Long Term ↗
March 21, 2022
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
News headline image
Looking Into PerkinElmer's Return On Capital Employed ↗
March 09, 2022
According to Benzinga Pro, during Q4, PerkinElmer (NYSE:PKI) earned $190.18 million, a 48.89% increase from the preceding quarter. PerkinElmer also posted a total of $1.36 billion... 
Via Benzinga
News headline image
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
February 10, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 3, 2022 ↗
March 03, 2022
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... 
Via Benzinga
News headline image
U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
February 03, 2022
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates ↗
February 02, 2022
PerkinElmer, Inc. reported fourth-quarter 2021 adjusted earnings per share (EPS) of $2.56, which beat the Consensus Estimate of $2.15 per share by 19.1%. 
Via Talk Markets
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap